Brief: Amylyx Pharmaceuticals Reports Q3 2024 Financial Results
07/11/2024 12:50
Nov 7 (Reuters) - Amylyx Pharmaceuticals Inc AMLX.O :
* AMYLYX PHARMACEUTICALS REPORTS THIRD QUARTER 2024
FINANCIAL
RESULTS
* AMYLYX PHARMACEUTICALS INC: CASH RUNWAY EXPECTED INTO 2026
Source text: ID:nBw1xMNp8a
Further company coverage: AMLX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amylyx Pharmaceuticals
See all newsU.S. STOCKS ON THE MOVE-LSI Industries, SiTime, Andersen Group
U.S. STOCKS ON THE MOVE-Apple, Hims & Hers Health, Sysco
U.S. STOCKS ON THE MOVE-Nordson, Nebius, Deere
Amylyx dips after increased $500 mln stock sale to fund blood sugar drug
Brief: Amylyx Pharmaceuticals Announces Pricing Of Upsized $500 Million Underwritten Public Offering Of Common Stock